Sort by
Refine Your Search
-
Country
-
Employer
- City of Hope
- University of Birmingham
- Harvard University
- The University of Queensland
- ADELAIDE UNIVERSITY
- Center for Biologics Evaluation and Research (CBER)
- Cold Spring Harbor Laboratory
- Dana-Farber Cancer Institute (DFCI)
- Hong Kong Polytechnic University
- Indiana University
- King's College London
- Nanyang Technological University
- National University of Singapore
- The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)
- University of Birmingham;
- University of British Columbia
- University of Maryland School of Medicine, Baltimore
- University of Washington
- Vanderbilt University
- 9 more »
- « less
-
Field
-
small molecules, as well as exciting new modalities (including ADCs and Immunotherapies). The key learning objectives of the fellowship program are to understand: • Scientific research process (including
-
of immunotherapy response or tertiary lymphoid structures. Experience applying machine learning and statistical modeling to biological or clinical datasets, including unsupervised clustering, dimensionality
-
to join a collaborative team of scientists in our lab. The successful candidate will work on developing novel approaches to enhance the efficacy of immunotherapy in treatment resistant cancers by modulating
-
, or immunotherapy. · Ability to work in a fast-paced research environment and manage multiple projects and collaborations. · Previous experience working with human specimens and developing novel
-
the Department of Immunology and Immunotherapy at the University of Birmingham. Screening is being considered as an appropriate health intervention, which identifies the disease pre-symptomatically and provides
-
and treatment response Studies of patient samples for tumor behavior and clinical outcomes in context of immunotherapy These projects are collaborative efforts between the Dana-Farber Cancer Institute
-
prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical